New biotechnology holding company ElevateBio launches in Cambridge, US

This article was originally published here

ElevateBio is backed by $150m funding raised through a Series A financing round co-led by the MPM Capital-managed UBS Oncology Impact Fund and F2 Ventures. Other investors in

The post New biotechnology holding company ElevateBio launches in Cambridge, US appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply